A. Al Farsi

Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab.

R. Cook, P. Major, K. Zbuk, 2015, Journal of gastrointestinal oncology.

Anti-angiogenic therapy in advanced non-small cell lung carcinoma (NSCLC): is there a role in subsequent lines of therapy?

P. Ellis, A. Al Farsi, 2015, Journal of thoracic disease.

Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees

Gheyath K Nasrallah, H. Yassine, D. Al-Sadeq, 2022, medRxiv.

Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment.

P. Ellis, H. Al-Shamsi, A. Al Farsi, 2014, Clinical lung cancer.